# Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

> **NCT00136864** · PHASE3 · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 310 (actual)

## Conditions studied

- Non-Small-Cell Lung Carcinoma

## Interventions

- **PROCEDURE:** PET Diagnostic Imaging

## Key facts

- **NCT ID:** NCT00136864
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2009-11
- **Final completion:** 2011-09
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2011-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136864, "Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00136864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*